Literature DB >> 23827350

Early T-cell precursor leukemia/lymphoma in adults and children.

Ashleigh Allen1, Anthony Sireci, Adrianna Colovai, Kerice Pinkney, Maria Sulis, Govind Bhagat, Bachir Alobeid.   

Abstract

Early T-cell precursor-ALL (ETP-ALL) is a subtype of T-ALL with a poor prognosis in children. We analyzed ETP-ALL compared to conventional T-ALL/LBL in both adults and children to determine any differences in clinical outcomes, based on the following parameters: induction failure, relapse, and survival. Patients with ETP-ALL have a higher risk of relapse, especially in children (in all patients, HR=4.08, p=0.127, and children, HR=11.63, p=0.025). ETP-ALL seems to have an increased risk of adverse outcomes, particularly in children. Larger studies are needed to better determine the prognosis of this subtype of T-ALL.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ALL; Acute leukemia; Adults; Children; Early T-cell precursors; Leukemia; Lymphoblastic; Lymphoma; Prognosis

Mesh:

Year:  2013        PMID: 23827350     DOI: 10.1016/j.leukres.2013.06.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  18 in total

1.  Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.

Authors:  Shannon L Maude; Sibasish Dolai; Cristina Delgado-Martin; Tiffaney Vincent; Alissa Robbins; Arthavan Selvanathan; Theresa Ryan; Junior Hall; Andrew C Wood; Sarah K Tasian; Stephen P Hunger; Mignon L Loh; Charles G Mullighan; Brent L Wood; Michelle L Hermiston; Stephan A Grupp; Richard B Lock; David T Teachey
Journal:  Blood       Date:  2015-02-02       Impact factor: 22.113

2.  KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.

Authors:  Fida Khater; Mathieu Lajoie; Sylvie Langlois; Jasmine Healy; Sonia Cellot; Chantal Richer; Patrick Beaulieu; Pascal St-Onge; Virginie Saillour; Mark Minden; Monia Marzouki; Maja Krajinovic; Henrique Bittencourt; Daniel Sinnett
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

Review 3.  New Approaches to Treating Challenging Subtypes of ALL in AYA Patients.

Authors:  Kevin Prescott; Michael Jacobs; Wendy Stock; Joseph Wynne
Journal:  Curr Hematol Malig Rep       Date:  2020-12       Impact factor: 3.952

4.  Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.

Authors:  B J Shields; R Alserihi; C Nasa; C Bogue; W S Alexander; M P McCormack
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

Review 5.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

Review 6.  The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities.

Authors:  Kathrin M Bernt; Stephen P Hunger; Tobias Neff
Journal:  Front Pediatr       Date:  2016-05-18       Impact factor: 3.418

7.  Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes.

Authors:  J E Brammer; R M Saliba; J L Jorgensen; C Ledesma; S Gaballa; M Poon; R T Maziarz; R E Champlin; C Hosing; P Kebriaei
Journal:  Bone Marrow Transplant       Date:  2016-09-12       Impact factor: 5.483

Review 8.  MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Katarzyna Gębarowska; Anna Mroczek; Jerzy R Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  Molecular Features of Three Children Diagnosed With Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Dongjin Park; Myungshin Kim; Yonggoo Kim; Kyungja Han; Jae Wook Lee
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

10.  Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.

Authors:  L Fransecky; M Neumann; S Heesch; C Schlee; J Ortiz-Tanchez; S Heller; M Mossner; S Schwartz; L H Mochmann; K Isaakidis; L Bastian; U R Kees; T Herold; K Spiekermann; N Gökbuget; C D Baldus
Journal:  J Hematol Oncol       Date:  2016-09-22       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.